Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-15-027541

Chief Scientific Officer sold 5,500 shares at $106.81 ($587,455)

  • Chief Scientific Officer acquired 5,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Biller Scott · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2015-03-16 Exercise or conversion : show line 1 in the form +5,500 $0.47 $2,571 48,270 D
2015-03-16 Sale : show line 2 in the form −5,500 $106.81 $587,455 42,770 D
Open-market sales · 5,500 sh · avg $106.81 · $587,455

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-03-16 Exercise or conversion : show line 3 in the form Stock option (right to buy) −5,500 $0.47 2020-12-06 5,500 302,817 D
Loading xslF345X03/doc4.xml…